Skip to main content

Table 2 Effectiveness assessments and timing of administration

From: An effectiveness-implementation hybrid trial study protocol targeting posttraumatic stress disorder and comorbidity

Study measure

Baseline

3 months

6 months

12 months

EHR 10 item PTSD evaluation [55]

X

   

ICD injury severity

X

   

ICD TBI severity

X

   

ICD/self-report chronic medical conditions

X

X

  

EHR and self-reported demographics

X

   

Consciousness/Glasgow Coma Scale [144, 145]

X

   

PTSD (PTSD Checklist DSM-IV & DSM-5) [58, 81]

X

X

X

X

Depression (PHQ-9) [82]

X

X

X

X

Suicidal ideation (PHQ-9 item 9) [82, 84]

    

Alcohol (AUDIT) [85]

X

X

X

X

Illegal and prescription drug use (DAST) [146]

X

X

X

X

Pain (Brief Pain Inventory) [147, 148]

X

X

X

X

Postconcussive symptoms [90, 149, 150]

X

X

X

X

Functioning (MOS SF12/36) [88]

X

X

X

X

Violence risk behaviors [24]

X

X

X

X

Pre-injury trauma [6, 106, 107]

 

X

  

Recurrent traumatic events [6, 106, 107]

  

X

X

Reactions to research participation [25]

X

X

X

X

Satisfaction with care [16, 25]

X

X

X

X

Health services, work and cost [14, 151154]

X

X

X

X

Medication use [14, 16, 25, 151]

X

X

X

X

EHR/trauma registry data [14, 151]

Ongoing automated data

  1. EHR electronic health record, PTSD posttraumatic stress disorder, ICD international classification of diseases, DSM Diagnostic and Statistical Manual of Mental Disorders, PHQ-9 Patient Health Questionnaire, AUDIT Alcohol Use Disorders Identification Test, DAST Drug Abuse Screen Test, MOS SF Medical Outcomes Study Short Form